- December 26, 2020
- Category: Healthcare and LifeSciences, Medical Device and Equipment
Global Inhaled Nitric Oxide Market Size Study by Product Type (Gas, Delivery Systems). By Application (Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome (ARDS), Malaria Treatment, Tuberculosis Treatment, Other Applications) and Regional Forecasting 2020-2027.
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion) 1.2.1. Inhaled Nitric Oxide Market, by Product Type, 2018-2027 (USD Billion) 1.2.2. Inhaled Nitric Oxide Market, by Application, 2018-2027 (USD Billion) 1.2.3. Inhaled Nitric Oxide Market, By Region, 2018-2027 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Inhaled Nitric Oxide Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Inhaled Nitric Oxide Market Dynamics 3.1. Inhaled Nitric Oxide Market Impact Analysis (2018-2027) 3.1.1. Market Drivers 3.1.2. Market Challenges 3.1.3. Market Opportunities Chapter 4. Global Inhaled Nitric Oxide Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economic 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Inhaled Nitric Oxide Market, by Product Type 5.1. Market Snapshot 5.2. Global Inhaled Nitric Oxide Market by Source, Performance - Potential Analysis 5.3. Global Inhaled Nitric Oxide Market Estimates & Forecasts by Product Type2018-2027 (USD Billion) 5.4. Inhaled Nitric Oxide Market, Sub Segment Analysis 5.4.1. Gas 5.4.2. Delivery Systems Chapter 6. Global Inhaled Nitric Oxide Market, by Application 6.1. Market Snapshot 6.2. Global Inhaled Nitric Oxide Market by Source, Performance - Potential Analysis 6.3. Global Inhaled Nitric Oxide Market Estimates & Forecasts by Application 2018-2027 (USD Billion) 6.4. Inhaled Nitric Oxide Market, Sub Segment Analysis 6.4.1. Neonatal Respiratory Treatment 6.4.2. Asthma and COPD (Chronic Obstructive Pulmonary Disease) 6.4.3. Acute Respiratory Distress Syndrome 6.4.4. Malaria Treatment 6.4.5. Tuberculosis Treatment 6.4.6. Other Applications Chapter 7. Global Inhaled Nitric Oxide Market, Regional Analysis 7.1. Inhaled Nitric Oxide Market, Regional Market Snapshot 7.2. North America Inhaled Nitric Oxide Market 7.2.1. U.S. Inhaled Nitric Oxide Market 18.104.22.168. Product breakdown estimates & forecasts, 2018-2027 22.214.171.124. Application breakdown estimates & forecasts, 2018-2027 7.2.2. Canada Inhaled Nitric Oxide Market 7.3. Europe Inhaled Nitric Oxide Market Snapshot 7.3.1. U.K. Inhaled Nitric Oxide Market 7.3.2. Germany Inhaled Nitric Oxide Market 7.3.3. France Inhaled Nitric Oxide Market 7.3.4. Spain Inhaled Nitric Oxide Market 7.3.5. Italy Inhaled Nitric Oxide Market 7.3.6. Rest of Europe Inhaled Nitric Oxide Market 7.4. Asia-Pacific Inhaled Nitric Oxide Market Snapshot 7.4.1. China Inhaled Nitric Oxide Market 7.4.2. India Inhaled Nitric Oxide Market 7.4.3. Japan Inhaled Nitric Oxide Market 7.4.4. Australia Inhaled Nitric Oxide Market 7.5. Latin America Inhaled Nitric Oxide Market Snapshot 7.6. Rest of The World Inhaled Nitric Oxide Market Chapter 8. Competitive Intelligence 8.1. Top Market Strategies 8.2. Company Profile 8.2.1. Air Liquide Healthcare 126.96.36.199. Key Information 188.8.131.52. Overview 184.108.40.206. Financial (Subject to Data Availability) 220.127.116.11. Product Summary 18.104.22.168. Recent Developments 8.2.2. Mallinckrodt 8.2.3. Matheson Tri-Gas Inc. 8.2.4. Merck KGaA 8.2.5. Novoteris 8.2.6. Nu-Med Plus 8.2.7. Perma Pure LLC 8.2.8. Praxair Technology Inc. 8.2.9. Beyond Air Inc. 8.2.10. Linde Plc (Praxair Inc.) Chapter 9. Research Process 9.1. Research Process 9.1.1. Data Mining 9.1.2. Analysis 9.1.3. Market Estimation 9.1.4. Validation 9.1.5. Publishing 9.2. Research Attributes 9.3. Research Assumption
Global Inhaled Nitric Oxide Market was valued at USD XX million in 2019 and expected to grow with a CAGR 8.1% over the forecasting period 2020-2027. Inhaled Nitric Oxide (INO) is a gas which inhaled through mouth. It is used together with ventilator machine and other machines which work in muscles smoothening to widen the blood vessels in the lungs. INO is identified as an intoxicating and selective pulmonary vasodilator that does not decrease systemic vascular tone. Increase in chronic diseases, accelerates the demand of INO in healthcare sector thus, driving the market growth of the global Inhaled Nitric Oxide market. Moreover, ncreasing number of patients with chronic obstructive pulmonary disease and increasing occurrence of diseases in the new-born babies such as neonatal hypoxic respiratory failure (HRF) and persistent pulmonary hypertension also enhanced the market growth. For Instance, as per JHEOR 2019 report ((Journal of Health Economics and Outcomes Research), the annual number of term and late pre-term new-borns with HRF is projected at 80000 in the United State alone. Despite that, strict application norms and High cost of treatment are hindering the growth of market over the forecasting period 2020-2027.
The regional analysis of the Inhaled Nitric Oxide Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. In which, North America is dominating region. Growing respiratory disease and asthma incidence was highest among workers in the healthcare and social assistance industry. However, APAC is emerged as fastest growing region over the forecasting period 2020-2027 due to highest live birth per 1000 people and increasing respiratory diseases.
Key Players in Global Inhaled Nitric Oxide Market
Air Liquide Healthcare
Matheson Tri-Gas Inc.
Perma Pure LLC
Praxair Technology Inc.
Beyond Air Inc.
Linde Plc (Praxair Inc.)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Neonatal Respiratory Treatment
Asthma and COPD (Chronic obstructive pulmonary disease)
Acute Respiratory Distress Syndrome (ARDS)
Rest of LA
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of Global Inhaled Nitric Oxide Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers